1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548466, C07D20934

Patent

active

048793914

ABSTRACT:
Certain substituted 1-phenyl-3-(aminoalkylidene)-2(1H,3H)-indolones are highly potent gabaergic agents, valuable in the treatment of individuals suffering from schizophrenia or reversing the side effects of a previously or concurrently administered neuroleptic agent; or in the treatment of epilepsy. A wider class of substituted 1-phenyl-3-(aminoalkylidene)-2(1H,3H)-indolones, together with 1-phenyl-3-(2-pyrrolidinylidiene-2(1H,3H)-indolones, and homologs thereof, are valuable in the treatment of anxiety.

REFERENCES:
patent: 3043849 (1962-07-01), Szmuskovicz
patent: 3215699 (1965-02-01), Shavel et al.
patent: 3506683 (1970-04-01), Anthony et al.
patent: 3642803 (1972-02-01), Welstead
patent: 3644403 (1972-02-01), Canas-Rodriguez et al.
patent: 3732248 (1973-05-01), Canas-Rodriguez et al.
patent: 4145422 (1979-03-01), Winn et al.
patent: 4332804 (1982-06-01), Clark
Latrell et al., CA 89:179858y, 1978.
Meyers et al., Review of Medicinal Pharmacology, 4th Ed., Lange Medical Publications, 1974, p. 149.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-84849

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.